Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)
Nuvectis Pharma (NVCT) reported Prepaid Assets of $268000.0 for Q1 2026, down 5.63% on a YoY basis from $284000.0 in Q1 2025, and up 257.33% sequentially from $75000.0 in Q4 2025.
Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 6 years of Prepaid Assets data on file, last reported at $268000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 5.63% year-over-year to $268000.0; the trailing twelve-month figure through Mar 2026 stood at $268000.0 (down 5.63% YoY), and the FY2025 full-year result was $75000.0, up 1.35% from the prior year.
- Prepaid Assets improved to $268000.0 in Q1 2026, from $75000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.2 million in Q3 2022 to a low of $59000.0 in Q4 2023.
- A 5-year average of $364823.5 and a median of $250000.0 in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 352.75% in 2022 and sank 85.68% in 2023, its largest moves.
- Tracing NVCT's Prepaid Assets over 5 years: stood at $412000.0 in 2022, then slumped by 85.68% to $59000.0 in 2023, then grew by 25.42% to $74000.0 in 2024, then advanced by 1.35% to $75000.0 in 2025, then soared by 257.33% to $268000.0 in 2026.
- Business Quant data shows NVCT's Prepaid Assets at $268000.0 in Q1 2026, $75000.0 in Q4 2025, and $145000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Nuvectis Pharma | 453.54 Mn | 453.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 284,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Dec 31, 2022 | 412,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 666,000.00 |
| Mar 31, 2022 | 925,000.00 |
| Dec 31, 2021 | 91,000.00 |